[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364145-105":59,"doc-detail-364145-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","impact-of-clinicopathological-and-institutional-factors-on-the-clinical-courses-of-patients-with-localized-prostate-cancer-initially-managed-by-active-surveillance-an-analysis-of-nationwide-real-world-data-from-japan","Impact of Clinicopathological and Institutional Factors on the Clinical Courses of Patients With Localized Prostate Cancer Initially Managed by Active Surveillance - An Analysis of Nationwide Real-World Data From Japan","","Investigates active surveillance (AS) continuation rates and the roles of clinicopathological and institutional factors in Japanese patients with localized prostate cancer. Retrospective nationwide real-world analysis included 989 patients from 92 institutions initiating AS between 2016 and 2018, with institutions grouped by AS uptake for low-risk disease and discontinuation triggers assessed. Over 3.4 years median follow-up, 47.0% discontinued AS; ≥2 comorbidities, ≥3 positive biopsy cores, and T2b–c stage shortened continuation, while higher AS-uptake institutions showed longer adjusted restricted mean continuation time differences. After discontinuation, most received prostatectomy, radiotherapy, or hormonal therapy. Institutional strategies significantly influenced post-AS treatment choices.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/impact-of-clinicopathological-and-institutional-factors-on-the-clinical-courses-of-patients-with-localized-prostate-cancer-initially-managed-by-active-surveillance-an-analysis-of-nationwide-real-world-data-from-japan/364145/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/impact-of-clinicopathological-and-institutional-factors-on-the-clinical-courses-of-patients-with-localized-prostate-cancer-initially-managed-by-active-surveillance-an-analysis-of-nationwide-real-world-data-from-japan/364145.png","ImageObject",300,407,{"name":92,"@type":93},"pixelkiddo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What study question and population were examined?","Question",{"text":112,"@type":113},"The study examined AS continuation and related clinical and institutional factors in Japanese patients with localized prostate cancer who initially started AS. Data included 989 patients from 92 institutions beginning AS between 2016 and 2018.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How often did patients discontinue active surveillance?",{"text":117,"@type":113},"Over a median follow-up of 3.4 years, 47.0% of patients discontinued AS. The median AS continuation time was 3.0 years, with a 5-year AS continuation rate of 33.7%.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were associated with shorter AS continuation time?",{"text":121,"@type":113},"Multivariable analysis found that having at least 2 comorbidities, at least 3 positive biopsy cores, and T2b–c stage were associated with restricted mean continuation time differences of about −0.6 to −0.8 years (all p \u003C 0.05).",{"name":123,"@type":110,"acceptedAnswer":124},"What treatments were given after discontinuation, and what role did institutions play?",{"text":125,"@type":113},"After discontinuation, 36.5% received prostatectomy, 39.2% received radiotherapy, and 24.3% received hormonal therapy. Institutional strategies, including AS uptake levels, significantly influenced treatment choices following AS, with multifaceted discontinuation triggers more common in higher AS-uptake institutions.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},364145,1790187008,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","International Journal of Urology  \n ORIGINAL ARTICLE  OPEN ACCESS   \nImpact of Clinicopathological and Institutional Factors on the Clinical Courses of Patients With Localized Prostate Cancer Initially Managed by Active Surveillance: An Analysis of Nationwide Real-World Data From Japan  \nMizuki Onozawa1  | Masaki Shiota2  | Taketo Kawai3  | Shinichi Sakamoto4  | Yoshiyuki Yamamoto5  | Satoru Taguchi6  | Yasuhide Kitagawa7 | Tohru Nakagawa8  | Shiro Hinotsu9  | Jun Miyazaki1  | Haruki Kume6 | Japan Study Group of Prostate Cancer (J-CaP)  \n1Department of Urology, International University of Health and Welfare Narita Hospital, Narita, Japan | 2Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan | 3Department of Urology, National Center for Global Health and Medicine, Tokyo,  \nJapan | 4Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan | 5Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan | 6Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan | 7Kitagawa UI Clinic, Komatsu, Japan | 8Department of Urology, Teikyo University School of Medicine, Tokyo, Japan | 9Department of Biostatistics and Clinical Epidemiology, Sapporo Medical University, Sapporo, Japan  \nCorrespondence: Mizuki Onozawa ([mizukionozawa@ihwg.jp](mizukionozawa@ihwg.jp))  \nReceived: 3 July 2026 | Revised: 31 August 2026 | Accepted: 8 September 2026  \nKeywords: active surveillance of prostate cancer | discontinuation | localized cancer | prostate cancer | real world evidence  \nABSTRACT  \nObjectives: To investigate active surveillance (AS) continuation rates and associated clinical and institutional factors in Japanese patients with localized prostate cancer.  \nMethods: We retrospectively analyzed 989 patients with localized prostate cancer from 92 institutions who initiated AS between 2016 and 2018. Institutions were categorized into three groups based on AS uptake for low-risk disease. Discontinuation triggersand subsequent treatments were examined.  \nResults: Median age was 70years; 66.2%, 26.0%, and 7.8% of patients had low-, intermediate-, and high-risk disease, respectively. Over a median follow-up of 3.4 years, 47.0% discontinued AS (median AS continuation time: 3.0 years; 5-year AS continuation rate: 33.7%). Multivariable analysis showed that ≥2 comorbidities, ≥3 positive biopsy cores, and T2b–c stage were associated with restricted mean continuation time differences (RMCTDs) of −0.6, −0.6, and −0.8years, respectively (all p \u003C 0.05) . Conversely, intermediate-and high-AS uptake institutions had significantly longer adjusted RMCTD (1.0 and 1.1 years, respectively; both p \u003C 0.001). Triggers for discontinuation were more often multifaceted in high-AS uptake institutions (39.1%) compared with lowor intermediate-AS uptake institutions (16.2% and 15.1%, respectively). After discontinuation, 36.5%, 39.2%, and 24.3% of patients received prostatectomy, radiotherapy, and hormonal therapy, respectively. With advancing age, the proportion of patients whose AS was discontinued due to PSA elevation increased, as did the rate of subsequent hormonal therapy.  \nConclusions: In Japanese real-world practice, AS continuation was limited. Beyond clinicopathological factors, institutional strategies for localized prostate cancer played a significant role in treatment choices following AS.  \n\n| Abbreviations: AS, active surveillance; GS, Gleason Score; IQR, interquartile range; PSA, prostate-specific antigen; RMCT, restricted mean continuation time; RMST, restricted mean survival time; RMSTD, restricted mean survival time difference; WW, watchful waiting. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.\u003Cbr>© 2026 The Author(s). ","cbCainAEBCynE9VR","https://ap.wps.com/l/cbCainAEBCynE9VR","pdf",709414,13,"English","# Introduction\n## Active surveillance for localized prostate cancer in Japan\n## Evolution of AS/WW selection rates over time","[{\"question\":\"What study question and population were examined?\",\"answer\":\"The study examined AS continuation and related clinical and institutional factors in Japanese patients with localized prostate cancer who initially started AS. Data included 989 patients from 92 institutions beginning AS between 2016 and 2018.\"},{\"question\":\"How often did patients discontinue active surveillance?\",\"answer\":\"Over a median follow-up of 3.4 years, 47.0% of patients discontinued AS. The median AS continuation time was 3.0 years, with a 5-year AS continuation rate of 33.7%.\"},{\"question\":\"Which factors were associated with shorter AS continuation time?\",\"answer\":\"Multivariable analysis found that having at least 2 comorbidities, at least 3 positive biopsy cores, and T2b–c stage were associated with restricted mean continuation time differences of about −0.6 to −0.8 years (all p \\u003c 0.05).\"},{\"question\":\"What treatments were given after discontinuation, and what role did institutions play?\",\"answer\":\"After discontinuation, 36.5% received prostatectomy, 39.2% received radiotherapy, and 24.3% received hormonal therapy. Institutional strategies, including AS uptake levels, significantly influenced treatment choices following AS, with multifaceted discontinuation triggers more common in higher AS-uptake institutions.\"}]","Impact of Clinicopathological and Institutional Factors on the Clinical Courses of Patients With Localized Prostate Cancer Initially Managed by Active Surveillance - An Analysis of Nationwide Real-World Data From Japan | PDF",1790156012,33,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a13baea2476a7a5d7b0ed50234d045cd.webp",983,1291,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/875ad6f64065961ac32a90c6fd713c04.webp",982,1290,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26ae8a05fe520731e2adce5c3c738681.webp",981,1289,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2dc503f047e2efbda514d8b63db6413.webp",980,1287]